HER2-low Breast Cancer: Salivary Metabolic Features and Therapeutic Perspectives
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The HER2-low breast cancer subgroup exhibits distinct immune and metabolic profiles, with heightened inflammation and altered amino acid levels. This finding highlights unique characteristics of HER2-low breast cancer, potentially guiding new therapeutic strategies.
Area Of Science
- Oncology
- Biochemistry
- Immunology
Background
- The metabolic and immune characteristics of HER2-low breast cancer remain largely undescribed.
- This study investigates immune reactivity, tumor markers, and amino acid profiles in HER2-low breast cancer.
Purpose Of The Study
- To delineate the unique metabolic and immune features of HER2-low breast cancer.
- To identify potential new therapeutic targets for HER2-low breast cancer patients.
Main Methods
- A case-control study analyzed saliva from 660 untreated breast cancer patients.
- Measured concentrations of cytokines, tumor markers, amino acids, and biochemical parameters.
Main Results
- The HER2-low group displayed the highest pro-inflammatory and lowest metabolic activity.
- Significant differences in three functional amino acid groups were observed in the HER2-low subgroup.
- Cancer antigen 19-9 (CA 19-9) showed the most significant deviations in the HER2-low group.
Conclusions
- HER2-low breast cancer patients possess distinct disease progression, immune response, and metabolic activity profiles.
- Understanding these metabolic features may reveal novel therapeutic targets for the HER2-low subgroup.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...